Ligand validation:5BO2

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BO2_IMD_B_401	90%	74%	0.083	0.965	0.42	0.57	-	-	0	0	100%	1
5BO2_IMD_A_401	72%	74%	0.12	0.945	0.4	0.6	-	-	1	0	100%	1
5BO2_IMD_B_402	57%	74%	0.132	0.906	0.41	0.57	-	-	0	0	100%	1
5BO2_IMD_B_403	51%	74%	0.146	0.9	0.42	0.57	-	-	0	0	100%	1
5BO2_IMD_A_402	41%	75%	0.17	0.884	0.43	0.53	-	-	1	0	100%	0.5
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	66%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.